IRINA SHCHEDROV: Open Payments
NPI 1669067013 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 11 payments from 9 companies in 2025. Trend: 2023 $537 · 2024 $954 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $275 |
| Teva Pharmaceuticals USA, Inc. | 2 | $252 |
| SPR Therapeutics, Inc | 1 | $133 |
| Incyte Corporation | 1 | $131 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| ALK-Abello, Inc | 1 | $119 |
| Gilead Sciences, Inc. | 1 | $118 |
| Alkermes, Inc. | 1 | $114 |
| Mallinckrodt Hospital Products Inc. | 1 | $96 |
Products named: SPRINT PNS System, AJOVY, Yeztugo, VIVITROL, TERLIVAZ.
Industry payments across CA — which companies pay providers there.
